H
Harrow Health, Inc.
HROW · NASDAQ · Healthcare · 1.5B
Price · close
$40.95
-2.64% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
28.9×
Enterprise value / EBITDAEV/EBITDA
40.7×
Free cash flow yieldFCF yield
2.8%
Return on equityROE
-9.8%
Operating margin
14.2%
Net debt / EBITDAbalance-sheet strength
4.3×
Interest coverage
1.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.